Important notice

The information on this page is intended for use only by knowledgeable and experienced professionals working in the healthcare and medical industry. By continuing, you automatically confirm that you are a professional working for a healthcare provider in a European country.

Yes No
18F-PSMA-1007

PróstaLumin

Description

This medicinal product is for diagnostic use only.
PróstaLumin is indicated for the detection of prostate-specific membrane antigen (PSMA)-positive lesions with positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical
settings:

  • Primary staging of patients with high-risk PCa prior to primary curative therapy,
  • Suspected PCa recurrence in patients with increasing levels of serum prostate-specific antigen (PSA) after primary curative therapy.

Specifications

Active Substance:

Fluorine (18F) PSMA-1007

Pharmacotherapeutic group:

Other diagnostic radiopharmaceutical for tumor detection

Form / Packaging:

Solution for Injection 20–4500 MBq/ml

Downloadable File